1887

Journal of General Virology header logo

Volume 98, Issue 2

Epstein–Barr virus nuclear antigen 1 interacts with regulator of chromosome condensation 1 dynamically throughout the cell cycle Free

Abstract

The Epstein–Barr virus (EBV) nuclear antigen 1 (EBNA1) is a sequence-specific DNA-binding protein that plays an essential role in viral episome replication and segregation, by recruiting the cellular complex of DNA replication onto the origin ( and by tethering the viral DNA onto the mitotic chromosomes. Whereas the mechanisms of viral DNA replication are well documented, those involved in tethering EBNA1 to the cellular chromatin are far from being understood. Here, we have identified regulator of chromosome condensation 1 (RCC1) as a novel cellular partner for EBNA1. RCC1 is the major nuclear guanine nucleotide exchange factor for the small GTPase Ran enzyme. RCC1, associated with chromatin, is involved in the formation of RanGTP gradients critical for nucleo-cytoplasmic transport, mitotic spindle formation and nuclear envelope reassembly following mitosis. Using several approaches, we have demonstrated a direct interaction between these two proteins and found that the EBNA1 domains responsible for EBNA1 tethering to the mitotic chromosomes are also involved in the interaction with RCC1. The use of an EBNA1 peptide array confirmed the interaction of RCC1 with these regions and also the importance of the N-terminal region of RCC1 in this interaction. Finally, using confocal microscopy and Förster resonance energy transfer analysis to follow the dynamics of interaction between the two proteins throughout the cell cycle, we have demonstrated that EBNA1 and RCC1 closely associate on the chromosomes during metaphase, suggesting an essential role for the interaction during this phase, perhaps in tethering EBNA1 to mitotic chromosomes.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): EBNA1 , EBV , Epstein–Barr virus , RCC1 and regulator of chromosome condensation 1
© 2017 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000681
2017-02-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/98/2/251.html?itemId=/content/journal/jgv/10.1099/jgv.0.000681&mimeType=html&fmt=ahah

References

  1. Crawford DH. Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 2001; 356:461–473 [View Article][PubMed]
     [Google Scholar]
  2. Kieff E, Rickinson AB. Epstein-Barr virus and its replication. In: Knipe DM. editor Fields Virology, 5th ed Wolters Kluwer/Lippincott Williams & Wilkins; 2007 pp. 2063–2654
     [Google Scholar]
  3. Adams A. Replication of latent Epstein-Barr virus genomes in Raji cells. J Virol 1987; 61:1743–1746[PubMed]
     [Google Scholar]
  4. Nanbo A, Sugden A, Sugden B. The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells. EMBO J 2007; 26:4252–4262 [View Article][PubMed]
     [Google Scholar]
  5. Yates JL, Guan N. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J Virol 1991; 65:483–488[PubMed]
     [Google Scholar]
  6. Yates J, Warren N, Reisman D, Sugden B. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 1984; 81:3806–3810[PubMed] [CrossRef]
     [Google Scholar]
  7. Yates JL, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985; 313:812–815[PubMed] [CrossRef]
     [Google Scholar]
  8. Reisman D, Yates J, Sugden B. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol Cell Biol 1985; 5:1822–1832[PubMed] [CrossRef]
     [Google Scholar]
  9. Rawlins DR, Milman G, Hayward SD, Hayward GS. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 1985; 42:859–868[PubMed] [CrossRef]
     [Google Scholar]
  10. Wysokenski DA, Yates JL. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. J Virol 1989; 63:2657–2666[PubMed]
     [Google Scholar]
  11. Chaudhuri B, Xu H, Todorov I, Dutta A, Yates JL. Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein–Barr virus. Proc Natl Acad Sci USA 2001; 98:10085–10089 [View Article][PubMed]
     [Google Scholar]
  12. Ritzi M, Tillack K, Gerhardt J, Ott E, Humme S et al. Complex protein-DNA dynamics at the latent origin of DNA replication of Epstein-Barr virus. J Cell Sci 2003; 116:3971–3984 [View Article][PubMed]
     [Google Scholar]
  13. Schepers A, Ritzi M, Bousset K, Kremmer E, Yates JL et al. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J 2001; 20:4588–4602 [View Article][PubMed]
     [Google Scholar]
  14. Sears J, Kolman J, Wahl GM, Aiyar A. Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1. J Virol 2003; 77:11767–11780[PubMed] [CrossRef]
     [Google Scholar]
  15. Sears J, Ujihara M, Wong S, Ott C, Middeldorp J et al. The amino terminus of Epstein-Barr virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J Virol 2004; 78:11487–11505 [View Article][PubMed]
     [Google Scholar]
  16. Wu DY, Krumm A, Schubach WH. Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2. J Virol 2000; 74:8893–8903[PubMed] [CrossRef]
     [Google Scholar]
  17. Wu H, Kapoor P, Frappier L. Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J Virol 2002; 76:2480–2490[PubMed] [CrossRef]
     [Google Scholar]
  18. Kirchmaier AL, Sugden B. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J Virol 1995; 69:1280–1283[PubMed]
     [Google Scholar]
  19. Little RD, Schildkraut CL. Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin. Mol Cell Biol 1995; 15:2893–2903[PubMed] [CrossRef]
     [Google Scholar]
  20. Deutsch MJ, Ott E, Papior P, Schepers A. The latent origin of replication of Epstein-Barr virus directs viral genomes to active regions of the nucleus. J Virol 2010; 84:2533–2546 [View Article][PubMed]
     [Google Scholar]
  21. Hodin TL, Najrana T, Yates JL. Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes. J Virol 2013; 87:13020–13028 [View Article][PubMed]
     [Google Scholar]
  22. Ambinder RF, Shah WA, Rawlins DR, Hayward GS, Hayward SD. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J Virol 1990; 64:2369–2379[PubMed]
     [Google Scholar]
  23. Ambinder RF, Mullen MA, Chang YN, Hayward GS, Hayward SD. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J Virol 1991; 65:1466–1478[PubMed]
     [Google Scholar]
  24. Bochkarev A, Barwell JA, Pfuetzner RA, Bochkareva E, Frappier L et al. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA. Cell 1996; 84:791–800[PubMed] [CrossRef]
     [Google Scholar]
  25. Frappier L, O'Donnell M. Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus. J Biol Chem 1991; 266:7819–7826[PubMed]
     [Google Scholar]
  26. Jones CH, Hayward SD, Rawlins DR. Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites. J Virol 1989; 63:101–110[PubMed]
     [Google Scholar]
  27. Shah WA, Ambinder RF, Hayward GS, Hayward SD. Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions. J Virol 1992; 66:3355–3362[PubMed]
     [Google Scholar]
  28. Lu F, Wikramasinghe P, Norseen J, Tsai K, Wang P et al. Genome-wide analysis of host-chromosome binding sites for Epstein-Barr virus nuclear antigen 1 (EBNA1). Virol J 2010; 7:262 [View Article][PubMed]
     [Google Scholar]
  29. Tempera I, De Leo A, Kossenkov AV, Cesaroni M, Song H et al. Identification of MEF2B, EBF1, and IL6R as direct gene targets of Epstein-Barr virus (EBV) nuclear antigen 1 critical for EBV-infected B-lymphocyte survival. J Virol 2015; 90:345–355 [View Article][PubMed]
     [Google Scholar]
  30. Mackey D, Middleton T, Sugden B. Multiple regions within EBNA1 can link DNAs. J Virol 1995; 69:6199–6208[PubMed]
     [Google Scholar]
  31. Mackey D, Sugden B. The linking regions of EBNA1 are essential for its support of replication and transcription. Mol Cell Biol 1999; 19:3349–3359[PubMed] [CrossRef]
     [Google Scholar]
  32. Coppotelli G, Mughal N, Marescotti D, Masucci MG. High avidity binding to DNA protects ubiquitylated substrates from proteasomal degradation. J Biol Chem 2011; 286:19565–19575 [View Article][PubMed]
     [Google Scholar]
  33. Coppotelli G, Mughal N, Masucci MG. The Gly-Ala repeat modulates the interaction of Epstein-Barr virus nuclear antigen-1 with cellular chromatin. Biochem Biophys Res Commun 2013; 431:706–711 [View Article][PubMed]
     [Google Scholar]
  34. Kanda T, Otter M, Wahl GM. Coupling of mitotic chromosome tethering and replication competence in Epstein-Barr virus-based plasmids. Mol Cell Biol 2001; 21:3576–3588 [View Article][PubMed]
     [Google Scholar]
  35. Marechal V, Dehee A, Chikhi-Brachet R, Piolot T, Coppey-Moisan M et al. Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol 1999; 73:4385–4392[PubMed]
     [Google Scholar]
  36. Kanda T, Horikoshi N, Murata T, Kawashima D, Sugimoto A et al. Interaction between basic residues of Epstein-Barr virus EBNA1 protein and cellular chromatin mediates viral plasmid maintenance. J Biol Chem 2013; 288:24189–24199 [View Article][PubMed]
     [Google Scholar]
  37. Hung SC, Kang MS, Kieff E. Maintenance of Epstein–Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. Proc Natl Acad Sci USA 2001; 98:1865–1870 [View Article][PubMed]
     [Google Scholar]
  38. Thomae AW, Pich D, Brocher J, Spindler MP, Berens C et al. Interaction between HMGA1a and the origin recognition complex creates site-specific replication origins. Proc Natl Acad Sci USA 2008; 105:1692–1697 [View Article][PubMed]
     [Google Scholar]
  39. Kapoor P, Lavoie BD, Frappier L. EBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by aurora family kinases. Mol Cell Biol 2005; 25:4934–4945 [View Article][PubMed]
     [Google Scholar]
  40. Nayyar VK, Shire K, Frappier L. Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2). J Cell Sci 2009; 122:4341–4350 [View Article][PubMed]
     [Google Scholar]
  41. Shire K, Ceccarelli DF, Avolio-Hunter TM, Frappier L. EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J Virol 1999; 73:2587–2595[PubMed]
     [Google Scholar]
  42. Kapoor P, Shire K, Frappier L. Reconstitution of Epstein-Barr virus-based plasmid partitioning in budding yeast. EMBO J 2001; 20:222–230 [View Article][PubMed]
     [Google Scholar]
  43. Kapoor P, Frappier L. EBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomes. J Virol 2003; 77:6946–6956[PubMed] [CrossRef]
     [Google Scholar]
  44. Jourdan N, Jobart-Malfait A, Dos Reis G, Quignon F, Piolot T et al. Live-cell imaging reveals multiple interactions between Epstein-Barr virus nuclear antigen 1 and cellular chromatin during interphase and mitosis. J Virol 2012; 86:5314–5329 [View Article][PubMed]
     [Google Scholar]
  45. Riddick G, Macara IG. A systems analysis of importin-α–β mediated nuclear protein import. J Cell Biol 2005; 168:1027–1038 [View Article][PubMed]
     [Google Scholar]
  46. Askjaer P, Galy V, Hannak E, Mattaj IW. Ran GTPase cycle and importins α and β are essential for spindle formation and nuclear envelope assembly in living Caenorhabditis elegans embryos. Mol Biol Cell 2002; 13:4355–4370 [View Article][PubMed]
     [Google Scholar]
  47. Bamba C, Bobinnec Y, Fukuda M, Nishida E. The GTPase Ran regulates chromosome positioning and nuclear envelope assembly in vivo. Curr Biol 2002; 12:503–507 [View Article][PubMed]
     [Google Scholar]
  48. Renault L, Nassar N, Vetter I, Becker J, Klebe C et al. The 1.7 Å crystal structure of the regulator of chromosome condensation (RCC1) reveals a seven-bladed propeller. Nature 1998; 392:97–101 [View Article][PubMed]
     [Google Scholar]
  49. Nemergut ME, Mizzen CA, Stukenberg T, Allis CD, Macara IG. Chromatin docking and exchange activity enhancement of RCC1 by histones H2A and H2B. Science 2001; 292:1540–1543 [View Article][PubMed]
     [Google Scholar]
  50. Renault L, Kuhlmann J, Henkel A, Wittinghofer A. Structural basis for guanine nucleotide exchange on Ran by the regulator of chromosome condensation (RCC1). Cell 2001; 105:245–255[PubMed] [CrossRef]
     [Google Scholar]
  51. England JR, Huang J, Jennings MJ, Makde RD, Tan S. RCC1 uses a conformationally diverse loop region to interact with the nucleosome: a model for the RCC1-nucleosome complex. J Mol Biol 2010; 398:518–529 [View Article][PubMed]
     [Google Scholar]
  52. Makde RD, England JR, Yennawar HP, Tan S. Structure of RCC1 chromatin factor bound to the nucleosome core particle. Nature 2011; 467:562–566 [CrossRef]
     [Google Scholar]
  53. Chen T, Muratore TL, Schaner-Tooley CE, Shabanowitz J, Hunt DF et al. N-terminal α-methylation of RCC1 is necessary for stable chromatin association and normal mitosis. Nat Cell Biol 2007; 9:596–603 [View Article][PubMed]
     [Google Scholar]
  54. Cushman I, Stenoien D, Moore MS. The dynamic association of RCC1 with chromatin is modulated by Ran-dependent nuclear transport. Mol Biol Cell 2004; 15:245–255 [View Article][PubMed]
     [Google Scholar]
  55. Li HY, Wirtz D, Zheng Y. A mechanism of coupling RCC1 mobility to RanGTP production on the chromatin in vivo. J Cell Biol 2003; 160:635–644 [View Article][PubMed]
     [Google Scholar]
  56. Hao Y, Macara IG. Regulation of chromatin binding by a conformational switch in the tail of the Ran exchange factor RCC1. J Cell Biol 2008; 182:827–836 [View Article][PubMed]
     [Google Scholar]
  57. Zhang C, Goldberg MW, Moore WJ, Allen TD, Clarke PR. Concentration of Ran on chromatin induces decondensation, nuclear envelope formation and nuclear pore complex assembly. Eur J Cell Biol 2002; 81:623–633 [View Article][PubMed]
     [Google Scholar]
  58. Zhang MS, Arnaoutov A, Dasso M. RanBP1 governs spindle assembly by defining mitotic Ran-GTP production. Dev Cell 2014; 31:393–404 [View Article][PubMed]
     [Google Scholar]
  59. Redondo-Muñoz J, Pérez-García V, Rodríguez MJ, Valpuesta JM, Carrera AC. Phosphoinositide 3-kinase beta protects nuclear envelope integrity by controlling RCC1 localization and Ran activity. Mol Cell Biol 2015; 35:249–263 [View Article][PubMed]
     [Google Scholar]
  60. Bierbaum M, Bastiaens PI. Cell cycle-dependent binding modes of the Ran exchange factor RCC1 to chromatin. Biophys J 2013; 104:1642–1651 [View Article][PubMed]
     [Google Scholar]
  61. Hutchins JR, Moore WJ, Hood FE, Wilson JS, Andrews PD et al. Phosphorylation regulates the dynamic interaction of RCC1 with chromosomes during mitosis. Curr Biol 2004; 14:1099–1104 [View Article][PubMed]
     [Google Scholar]
  62. Li HY, Zheng Y. Phosphorylation of RCC1 in mitosis is essential for producing a high RanGTP concentration on chromosomes and for spindle assembly in mammalian cells. Genes Dev 2004; 18:512–527 [View Article][PubMed]
     [Google Scholar]
  63. Hadjebi O, Casas-Terradellas E, Garcia-Gonzalo FR, Rosa JL. The RCC1 superfamily: from genes, to function, to disease. Biochim Biophys Acta 2008; 1783:1467–1479 [View Article][PubMed]
     [Google Scholar]
  64. Hussain M, Gatherer D, Wilson JB. Modelling the structure of full-length Epstein-Barr virus nuclear antigen 1. Virus Genes 2014; 49:358–372 [View Article][PubMed]
     [Google Scholar]
  65. Chakravorty A, Sugden B. The AT-hook DNA binding ability of the Epstein Barr virus EBNA1 protein is necessary for the maintenance of viral genomes in latently infected cells. Virology 2015; 484:251–258 [View Article][PubMed]
     [Google Scholar]
  66. Uchida S, Sekiguchi T, Nishitani H, Miyauchi K, Ohtsubo M et al. Premature chromosome condensation is induced by a point mutation in the hamster RCC1 gene. Mol Cell Biol 1990; 10:577–584[PubMed] [CrossRef]
     [Google Scholar]
  67. Piolot T, Tramier M, Coppey M, Nicolas JC, Marechal V. Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J Virol 2001; 75:3948–3959 [View Article][PubMed]
     [Google Scholar]
  68. Barbera AJ, Chodaparambil JV, Kelley-Clarke B, Joukov V, Walter JC et al. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 2006; 311:856–861 [View Article][PubMed]
     [Google Scholar]
  69. Krithivas A, Fujimuro M, Weidner M, Young DB, Hayward SD. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J Virol 2002; 76:11596–11604[PubMed] [CrossRef]
     [Google Scholar]
  70. Xiao B, Verma SC, Cai Q, Kaul R, Lu J et al. Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores. J Virol 2010; 84:9718–9732 [View Article][PubMed]
     [Google Scholar]
  71. Bazot Q, Deschamps T, Tafforeau L, Siouda M, Leblanc P et al. Epstein-Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1. Nucleic Acids Res 2014; 42:9700–9716 [View Article][PubMed]
     [Google Scholar]
  72. Pellet J, Tafforeau L, Lucas-Hourani M, Navratil V, Meyniel L et al. ViralORFeome: an integrated database to generate a versatile collection of viral ORFs. Nucleic Acids Res 2010; 38:D371–D378 [View Article][PubMed]
     [Google Scholar]
  73. Kramer A, Reineke U, Dong L, Hoffmann B, Hoffmüller U et al. Spot synthesis: observations and optimizations. J Pept Res 1999; 54:319–326 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000681
Loading
Epstein–Barr virus nuclear antigen 1 interacts with regulator of chromosome condensation 1 dynamically throughout the cell cycle
J. Gen. Virol. 98, 251 (2017); https://doi.org/10.1099/jgv.0.000681
/content/journal/jgv/10.1099/jgv.0.000681
/content/journal/jgv/10.1099/jgv.0.000681
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error